异基因干细胞移植后急性白血病患者早期念珠菌血症的发生率、危险因素及长期结局:欧洲血液和骨髓移植学会急性白血病与感染性疾病工作组研究
该研究分析2000至2012年接受异基因造血干细胞移植的28542例急性白血病患者,100天内念珠菌血症发生率为1.2%,中位发生时间为移植后22天。念珠菌血症患者100天非复发死亡风险更高(HR 3.0)且总生存更低(HR 2.5),100天病死率为22%。100天时存活者中,念珠菌血症是更高非复发死亡(HR 1.7)和更低总生存(HR 1.4)的独立危险因素。
要点
- 移植后100天内念珠菌血症发生率为1.2%,中位发生时间为移植后22天。
- 念珠菌血症患者100天非复发死亡风险更高(HR 3.0),总生存更低(HR 2.5)。
- 100天时存活者中,念珠菌血症是更高非复发死亡(HR 1.7)和更低总生存(HR 1.4)的独立危险因素。
核心结论
- 移植后早期发生念珠菌血症仍与更高的非复发死亡和更低的短期及长期总生存相关。
研究设计与样本
- 对2000至2012年接受异基因造血干细胞移植的28542例急性白血病患者进行结局分析。
- 347例患者在100天内发生念珠菌血症,28195例无念珠菌血症或任何其他类型念珠菌感染。
主要发现
- 100天内念珠菌血症发生率为1.2%,中位发生时间为移植后22天。
- 念珠菌血症患者100天非复发死亡风险更高(HR 3.0,P < .0001),100天总生存更低(HR 2.5,P < .0001)。
- 念珠菌血症患者100天病死率为22%(76/347)。
- 与念珠菌血症发生相关的因素为女性、骨髓或脐带血干细胞来源、T细胞去除、使用全身照射以及急性移植物抗宿主病。
- 100天时存活者中,中位随访5.6年(95%CI 5.5-5.7)时,念珠菌血症患者与无念珠菌血症患者的5年非复发死亡分别为22.5% vs 13.5%(P < .0001),5年总生存分别为45.6% vs 53.4%(P = .0003)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study was performed to assess the incidence of and risk factors for Candida infection in the first 100 days after allogeneic hematopoietic stem cell transplantation (HSCT) and the impact on long-term survival. METHODS: We performed an outcome analysis of 28542 acute leukemia patients who underwent HSCT from 2000 to 2012. There were 347 patients with candidemia by day 100 and 28195 without candidemia or any other type of Candida infection. RESULTS: The incidence of candidemia by day 100 was 1.2% and occurred at a median of 22 days after HSCT. Higher 100-day nonrelapse mortality (NRM; hazards ratio [HR], 3.0, P < .0001) and lower 100-day overall survival (OS; HR, 2.5, P < .0001) were observed in patients with candidemia. The case fatality rate by day 100 in patients with candidemia was 22% (76/347). Factors associated with candidemia occurrence were female gender, bone marrow or cord blood stem cell source, T-cell depletion, use of total body irradiation, and acute graft vs host disease. Among the patients alive at day 100, the 5-year NRM and OS after a median follow-up of 5.6 years (95% confidence interval, 5.5 - 5.7) for patients with and without candidemia were 22.5% vs 13.5%, P < .0001 and 45.6% vs. 53.4%, P = .0003, respectively. In multivariate analysis, the occurrence of a candidemia episode by day 100 was an independent risk factor for higher NRM (HR, 1.7, P = .001) and lower OS (HR, 1.4, P = .001). CONCLUSIONS: The early occurrence of candidemia after HSCT is still associated with higher NRM and lower short- and-long-term OS.
引用
- Cesaro S, Tridello G, Blijlevens N, et al. Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation. Clin Infect Dis. 2018. PMID: 29481599. doi:10.1093/cid/ciy150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。